Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial
Background Natural killer (NK) cells are one of the main effector populations of immunotherapy with monoclonal antibody and cytokines, used in combination with chemotherapy to treat children with high-risk neuroblastoma on this phase II trial. However, the impact of chemoimmunotherapy on NK cell kin...
Saved in:
| Main Authors: | Rosa Nguyen, David Cullins, Barbara Rooney, Natasha Sahr, April Sykes, Mary Beth McCarville, Sara M Federico, Amanda Sooter, William E Janssen, Gwendolyn Anthony, Michael A Dyer, Alberto S Pappo, Wing H Leung, Wayne L Furman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/1/e000176.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparing the Social Networks of Students Enrolled in Inclusive Postsecondary Education Programs and their Peers Enrolled in Traditional College Programs
by: Jennifer Bumble, et al.
Published: (2025-04-01) -
Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors
by: Irene Veneziani, et al.
Published: (2018-01-01) -
GD2-CAR NK-92 cell activity against neuroblastoma cells is insusceptible to TIGIT knockout
by: Wiebke Jünemann, et al.
Published: (2025-05-01) -
The Influence of the COVID-19 Pandemic in NK Cell Subpopulations from CML Patients Enrolled in the Argentina Stop Trial
by: María Belén Sanchez, et al.
Published: (2025-04-01) -
Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts
by: Yaya Chu, et al.
Published: (2024-06-01)